image: The reporter molecule based on EGFP (a fluorescent molecule) fused to the MYC protein was localized in the nucleus of cells. This material relates to a paper that appeared in the Jul. 16, 2019, issue of Science Signaling, published by AAAS. The paper, by D.R. Blake at University of North Carolina at Chapel Hill in Chapel Hill, NC; and colleagues was titled, 'Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.' view more
Credit: D.R. Blake <i>et al., Science Signaling</i> (2019)